Diabetes – Medical Alley Association

Diabetes

Minnesota Pharmacists Successfully Intervene to Close Care Gaps for Patients with Diabetes

MNCM releases findings from study on the health impact of enhanced pharmacy services MINNEAPOLIS (December 9, 2020) – MN Community Measurement today announced results from a 12-month study on the impact of pharmacy-based engagement to close gaps in care for patients with diabetes. The study is part of the organization’s broader efforts to empower health care […]

Innovative Program Predicts and Prevents Adverse Drug Events

WEA Trust, Predictive Health Partners and CHC Health Partner to Control Healthcare Costs and Improve Member Health  Madison, WI—WEA Trust, a local Wisconsin health plan, completed a Comprehensive Medication Therapy Management Pilot program to improve member health, lower adverse  drug event risks and control costs. In total, the program saved members over $100,000 and deprescribed medications […]

Medtronic Expands Diabetes Support Programs to Help Customers Losing Insurance Coverage Due to Job Loss as a Result of COVID-19

Via Medtronic Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced an expansion of the Medtronic Assurance program with a new option to support diabetes customers who have lost their health insurance due to COVID-19-related job loss. Current eligible U.S. customers can now receive a 3-month supply of glucose sensors, infusion sets and […]

How Abbott’s Continuous Glucose Monitoring System Joined the COVID-19 Fight

Via MDDI Online “Abbott said it has partnered with the American Diabetes Association, Insulin for Life USA, and the Diabetes Disaster Response Coalition to donate 25,000 FreeStyle Libre 14-day sensors to U.S. hospitals and medical centers in outbreak hotspots to help accelerate access to the technology.” “According to a recent report from the Centers for Disease Control and Prevention, […]

Abbott’s FreeStyle® Libre 14 DAY System Now Available in U.S. For Hospitalized Patients with Diabetes During COVID-19 Pandemic

Via Abbott Abbott (NYSE: ABT) announced today that the FreeStyle Libre 14 day system, the world’s leading3 continuous glucose monitoring (CGM) technology, can now be used in the hospital setting2 during the COVID-19 pandemic, according to the U.S. Food and Drug Administration (FDA). This will permit frontline healthcare workers to remotely monitor patients with diabetes receiving inpatient care by assessing […]

For The Record with Lonny Stormo, CEO, Pops Diabetes Care

What does Pops Diabetes Care Do? The Pops® one System is a virtual diabetes management platform. The system combines the power of the user’s phone with an app and an integrated glucose monitor. People who use the system can manage their condition through their phone using a simple experience, leading to improved outcomes.   You’re making a true connected device that bridges digital health and medical […]

POPS! Diabetes Care Announces the Commercial Launch of their POPS!® one System

MINNEAPOLIS — (BUSINESS WIRE) — POPS! Diabetes Care announces the commercial launch of their POPS!® one diabetes management system following FDA clearance in November. The system is different from all other solutions in that it combines a simple consumer experience with virtual care recommendations. “Our team has developed this solution for people with diabetes. It is an amazing […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER